In fact, after having been first reported by us, the reduction of specific homodimers of apoA2-i with C-terminal amino acid sequences has been confirmed in pancreatic cancer by several international research groups [12, 13]. The gene discussed is APOA2; the disease is pancreatic neoplasm.